Greenlight Biosciences
company
Funding Round
Post-IPO Equity
Money Raised
$ 125.50M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| BNP Paribas Asset Management | - | - | - | Detail |
| Continental Grain Company | - | - | - | Detail |
| Cormorant Asset Management | - | - | - | Detail |
| Fall Line Capital | - | - | - | Detail |
| Hudson Bay Capital Management | - | - | - | Detail |
| Jeremy and Hannelore Grantham Environmental Trust | - | - | - | Detail |
| MLS Capital Fund II | - | - | - | Detail |
| Morningside Venture Investments | - | - | - | Detail |
| Pura Vida Investments | - | - | - | Detail |
| Rivas Capital | - | - | - | Detail |
| S2G Ventures | - | - | - | Detail |
| Serum Life Sciences | - | - | - | Detail |
| Spruce Capital Partners | - | - | - | Detail |
| Viceroy Ventures | - | - | - | Detail |
| Xeraya Capital | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Sep 13, 2017 | Series D | $ 18M | Fall Line Capital,Kodiak Venture Partners,etc. | Detail |
| Dec 20, 2013 | Series A | $ 1M | Detail | |
| Jan 8, 2019 | Series Unknown | $ 50M | Alexandria Venture Investments,Baird Capital,etc. | Detail |
| Jul 22, 2015 | Series C | 0 | Syngenta Ventures | Detail |
| Aug 12, 2013 | Series A | $ 7M | Khosla Ventures,Kodiak Venture Partners | Detail |
| May 12, 2020 | Series Unknown | $ 17M | Baird Capital,Flu Lab,etc. | Detail |
| Jun 17, 2015 | Series B | $ 20M | Detail | |
| Jun 16, 2020 | Series D | $ 102M | AgFunder,Baird Capital,etc. | Detail |
